In the third week of this month (March), LB Investment and GI Innovation will conduct demand forecasting.



◆LB Investment= LB Investment is the successor of LG Startup Investment and changed its name to LB Investment in 2008 following a spin-off. Over 27 years, it has invested in about 540 promising domestic and international companies, with a cumulative investment scale reaching 1.7 trillion KRW. Recently, it successfully raised a fund of approximately 240 billion KRW, increasing the company's assets under management (AUM) to about 1.2 trillion KRW.


The total number of shares offered is 4.62 million. The desired price band per share is 4,400 to 5,100 KRW, with a maximum planned offering amount of about 23.6 billion KRW. Demand forecasting for institutional investors will be conducted on the 13th and 14th to finalize the offering price, followed by a general subscription on the 20th and 21st. The lead underwriter for the listing is Mirae Asset Securities.


◆GI Innovation= GI Innovation is a bio-venture company researching and developing next-generation immunotherapies based on fusion proteins, focusing on immune oncology and immune disease treatments. To date, it has completed two technology transfers worth 2.3 trillion KRW to pharmaceutical companies such as Korea’s Yuhan Corporation and China’s Simcere.


The total number of shares offered is 2 million, with a desired price band of 16,000 to 21,000 KRW. Demand forecasting will be conducted on the 15th and 16th to finalize the offering price, followed by a general subscription over two days on the 21st and 22nd. The lead underwriters are NH Investment & Securities and Hana Securities, with Samsung Securities as a joint underwriter.





This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing